Webinar on the various mechanisms of support offered by NIAID to facilitate discovery and development of anti-infectives

21 February 2019
Time: 17:00-18:30 CET

In this presentation, Ann Eakin (US National Institute of Allergy and Infectious Diseases, NIAID) provided an overview of the various mechanisms of support offered by NIAID to facilitate the discovery and development of drugs, vaccines, and diagnostics targeting infectious diseases. Dan Pevear, Senior Vice President, Biology and Grants Development, VenatoRx Pharmaceuticals, shared VenatoRx’ experience with NIAID support mechanisms.

Watch the webinar

Antimicrobial Chemotherapy Conference 2019

15 January 2019
London, UK

Laura Piddock, Head of Scientific Affairs, and Astrid Pentz-Murr, Community manager REVIVE – session on tackling beta-lactamase mediated resistance
Emilie Alirol, Project Leader, Sexually Transmitted Infections – presentation on the development of a new drug for STIs

World Health Summit 2018

14-16 October 2018
Berlin, Germany

Laura Piddock, Head of Scientific Affairs, GARDP – workshop on antibiotic R&D

IUSTI 2018 World & Europe Congress

27-30 June 2018
Dublin, Ireland

Jessica Renaux, Clinical Trial Manager, STI Programme, GARDP – session on antimicrobial resistance in gonorrhea and round table on strengthening STI case management in resource-constraint settings